We invest in visionary teams with transformative ideas.

Join Canaan's extended family.
222
companies
937
Jobs
Trishula Therapeutics
Trishula Therapeutics
trishulatx.com

Locations

South San Francisco, CA, USA

industry

Biotechnology · DeepTech · Health

Size

11-50 employees

Stage

Other

founded in

2020

Trishula is a privately held company dedicated to the development of TTX-030, a first-in-class, anti-CD39 antibody, in collaboration with AbbVie. TTX-030 inhibits the activity of CD39, an enzyme that converts ATP to AMP, the initial step in the generation of adenosine in the tumor microenvironment. TTX-030 prevents the formation of immune-suppressive extracellular adenosine and maintains high levels of immune-activating extracellular ATP, stimulating dendritic and myeloid-derived cells necessary for both innate and adaptive immunity. Currently, TTX-030 is being studied in phase 1/1b clinical trials as a monotherapy and in combination with an anti-PD-1 agent and standard chemotherapy in adults with advanced cancer (NCT03884556 and NCT04306900).

Something looks off?
Open jobs at Trishula Therapeutics
This company does not have jobs relevant to this job board at this time.
To view all their jobs, visit their website.